Heart Failure: Preserved or Reduced

8:30am Thursday, 14 November 2019
12:30pm Thursday, 14 November 2019
Seminar
Gold Coast Convention & Exhibition Centre
2684-2690 Gold Coast Hwy
Broadbeach, Queensland 4218
Australia

This half day pre-conference session will discuss the current therapies for managing Heart Failure.  It will highlight the different approaches to management of those with preserved ejection fraction and those with reduced ejection fraction.  The first session will discuss the management of the patient with reduced ejection fraction, presented by Dr Kuljit Singh on how he manages these patients.  Professor Scott McKenzie will follow this with a discussion on the management of patients with preserved ejection fraction, discussing the possibilities that may arise from ongoing trials.

The interactive workshops will be driven by Clinical Pharmacists already involved in multidisciplinary heart failure programs.  They will highlight the specific roles for specialist pharmacist input in the management of patients with heart failure in both hospital and community settings.

Preliminary Program

 

Registration ratesMember Non-Member
 $175$230

REGISTER HERE

Registration for this workshop is independent of MM2019 and you can register without attending the conference.

 

 

Contact Information

Additional Information

  • Professor Scott McKenzie
  • Victoria Warner

Learning objectives:

  • Standard 3.1.2 Assess medication management practices and needs
  • Standard 3.3.1 Undertake a clinical review
  • Standard 3.3.2 Apply clinical review findings to improve health outcomes
  • Standard 4.7.6 Work across service delivery boundaries

National Competency Standards Framework for Pharmacists in Australia, 2016

Accreditation:

This activity has been accredited for 2 hours of Group-1 CPD (or 2 CPD credits) and 1.5 hours of Group 2 CPD (or 3 CPD credits) – a total of 5 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/88.

APC